chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by the wife of a consumer and described the occurrence of overdose in a 69-year-old male subject who was vaccinated with Flu vaccine (manufacturer unspecified). A physician or other health care professional has not verified this report. Concurrent medical conditions included dementia, depression, dissociative amnesia, heart condition and protein S deficiency. Concurrent medications included Lopressor, Namenda, Aricept and other unknown medication. On 8 November 2008 the subject inadvertently received a 3rd dose of Flu vaccine. The consumer's wife explained that her husband (the subject) inadvertently received three influenza vaccines within a 60 day period. This was considered to be an overdose. It was mentioned upon reporting that the subject had been admitted to multiple facilities for unexplained reasons during that time frame. At an unspecified time following the 3rd flu shot, it was reported that the subject had not eaten well in 51 days. He experienced weakness making him unable to walk. He fell and hit his head and was found in a pool of fresh blood. He was admitted to the intensive care unit on 11 November 2008. he was being treated with a feeding tube at the time of report, but other treatments were unknown. The reporter was unsure which brand of vaccine the subject had received and was unsure if his symptoms were related. The outcome of the events was not specified.
Syncope happened twice on 1/8/23. Went to hospital emergency where they did all the blood tests and EKG as well. Everything was normal.
Patient 2 days later developed left-sided facial droop, left sided arm weakness and left sided diminished sensation.  Right  anterior cerebral artery infarction was demonstrated on CT angiography.
1st dose Sep2019, no 2nd dose yet / 1st 2 years ago; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in September 2019, intramuscularly).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The case was self reported by the patient. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix as per the vaccination schedule, which led to incomplete course of vaccination. The patient received Shingrix 2 years ago and was asking what should be done. The reporter did not have lot number, expiry date and date of administration for the first dose of Shingrix. The reporter consented to follow up with Healthcare professional. However, had very limited Healthcare professional contact information.
This spontaneous report as received from a health care worker refers to a 4 year old patient. On 16-SEP-2014, the 4 year old patient was vaccinated with ZOSTAVAX via, (dosage information unknown) subcutaneously. No concomitant medication was reported. No known adverse effects were reported. A product quality complaint PQC was not involved. Additional information has been requested.
killed my mother; This case was reported by a consumer via interactive digital media and described the occurrence of death in a adult female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced death (serious criteria death and GSK medically significant). On an unknown date, the outcome of the death was fatal. The reported cause of death was unknown cause of death.   The reporter considered the death to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. This vaccine killed the patient's mother. The follow-up would not possible as no contact details were available.; Reported Cause(s) of Death: Unknown cause of death
Received varivax on 8/13/2007.  Last night mom noticed redness and induration at site 2cmx3cm, no pain.
I was asleep I woke up coughing. Feeling like I swallowed my necklace( it felt like there was a string in my throat) and labored breathing. Rash developed all over body that is similar to the rash Kawasaki syndrome kids get.  Was taken to emergency room where I was given iv steroids and epi. 10-15 mins after my breathing was back to baseline and throat felt better. I have never had any trouble breathing or any allergic reactions to anything in the past.
did not get her 2nd dose; Dermatographia; Hives; Other allergies; Immune system hyperactive; This spontaneous case was reported by a patient and describes the occurrence of URTICARIA (Hives), MULTIPLE ALLERGIES (Other allergies), IMMUNE SYSTEM DISORDER (Immune system hyperactive), PRODUCT DOSE OMISSION ISSUE (did not get her 2nd dose) and MECHANICAL URTICARIA (Dermatographia) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (in the past allergy to and had anaphylactic reaction percocet). Concomitant products included MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced URTICARIA (Hives), MULTIPLE ALLERGIES (Other allergies) and IMMUNE SYSTEM DISORDER (Immune system hyperactive). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (did not get her 2nd dose) and MECHANICAL URTICARIA (Dermatographia). The patient was treated with OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives), MULTIPLE ALLERGIES (Other allergies), IMMUNE SYSTEM DISORDER (Immune system hyperactive) and PRODUCT DOSE OMISSION ISSUE (did not get her 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   patient stated that she went to allergist and result are awaiting. In the past she had allergic to and had anaphylactic reaction to Percocet. She thoughts she might be allergic to or hypersensitive to polyethylene glycol but not sure.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: VAERS ADR form
Injection on Friday, by Sunday afternoon had severe pain in upper arm/shoulder/neck...debilitating pain.  Loss of strength in left arm over the course of the following week, accompanied by extreme discomfort and muscle issues.
Initial unsolicited report received from a health-care professional on 13-Oct-2017. This case involves male patient (gender not reported) of unknown age who was vaccinated with dose of FLUZONE ID (batch number: UT5902AA, expiry date, dose, dose in series, route and site of administration were not reported) on an unknown date. Patient's medical history and concomitant medications were not reported. On unknown date, following the vaccination, patient experienced radiating pain up arm into neck and swollen red arm. Lab data and corrective treatment were unknown. The event outcome was unknown at the time of reporting. List of documents held by sender: none.
Bilateral hands swelled up, increase in body temp.  Patient took Claritin D at 1600 and symptoms subsided.
Cellulitis of left thigh at site of PEDIARIX immunization. Rx: BACTRIM x 7 days.
Patient came in for her first dose of Moderna vaccine. After she received her vaccine she was in the waiting area and began to complain of dizziness and stated she felt as if she was going to faint. She also began to complain of arm tingling on the left side. When I went to check her blood pressure, she felt very clammy to the touch. Prior to calling EMS, her blood pressure was taken twice approximately ten minutes apart. The first reading was 93/52 mmHg with a pulse of 45 and the second reading was 93/62 mmHg with a pulse of 68. EMS arrived and monitored her for approximately ten minutes and stated her vitals were beginning to stabilize and she would not need to be transported to a medical facility. I monitored the patient for an additional ten minutes after to this to ensure she felt okay  before allowing her to leave.
Awoke with Dizziness 10May2021 could not pick my head up from the bed x 2 hours.  Dizziness lasted until 20May2021in spurts especially when I had to bend head down.; Awoke with Dizziness 5/10/ 2021 could not pick my head up from the bed x 2 hours.  Dizziness lasted until 5/20/2021 in spurts especially when I had to bend head down.; Weakness; This is a spontaneous report received from a contactable other hcp via reporting system. A 64-year-old (non-pregnant) female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Formulation: Solution for injection, Batch/Lot Number: EW0170), dose 1 via an unspecified route of administration, administered in Arm Left on 21Apr2021 09:00 (at the age 64-year-old) as 1ST DOSE, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included metoprolol and ergocalciferol (VITAMIN D [ERGOCALCIFEROL]) for an unspecified indication. The patient experienced dizziness and head discomfort on 10May2021 at 06:00 and weakness in May2021. The patient stated that "awoke with dizziness 10May2021 could not pick my head up from the bed x 2 hours. dizziness lasted until 20May2021 in spurts especially when i had to bend head down". Therapeutic measures were taken as a result of events; fluticasone 50MCG SPR Roxane & Zyrtec was given. Outcome of the event weakness was unknown and other events was recovering.  Follow-up attempts are completed. No further information is expected.
Not feeling well; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): NVSC2021US235393.  A 53 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation; secukinumab (COSENTYX), first regimen details not provided (Batch/Lot number: unknown) and second regimen details not provided (Batch/Lot number: unknown). The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "Not feeling well".  Additional information: Patient had taken 2 doses of Cosentyx. She stated she had taken the 2 doses of inconsistently because she received the Covid vaccine. Her healthcare provider wanted her to wait taking her Cosentyx so she held back dose after receiving the Covid vaccine. Patient stated she was not feeling well.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Reddened lump on right thigh.  Right thigh swelling with cellulitis.
Pain at injection site for first dose; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 62 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in leg left, administration date 30Mar2021 10:45 (Lot number: ER2613) at the age of 61 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Allergies: Penicillin" (unspecified if ongoing), notes: Known allergies: Penicillin. Concomitant medication(s) included: VALACYCLOVIR [VALACICLOVIR]; MONTELUKAST; CITALOPRAM. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Pain at injection site for first dose". Therapeutic measures were not taken as a result of vaccination site pain.  Additional information: Patient did not received any other vaccine in four weeks. Patient was not diagnosed with covid prior and post vaccination. Vaccination facility was other.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021476696 Same reporter, patient, and product; different events and dose
I was fine after receiving the vaccine. On 12/26/2022 I began not feeling well with a cough, fatigue and fever. I went to an urgent care center on 12/30/2022 and I was advised to take guaifenesin and acetaminophen for my symptoms. I was sick for three to four weeks. As of today, I continue to have a cough and nasal congestion. I have tested positive for COVID-19 twice. First was 12/21/2021 and on 08/02/2022. I noticed that I have hair loss since I have had COVID-19. Last summer is when I noticed the hair loss.
pt recv vax 8JUN96 & 21JUN96 pt devel a fever of 101 to 103 which persisted x 2 days;mom thought that fever might have been r/t vax;22JUN96 pt to MD dx w/hand, foot & mouth disease;reporter felt that was no correlation between exp & vax;
Joint swelling; increase in neck pain.; Also had fatigue; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 04Mar2021 14:30 (Lot number: EN6206) at the age of 50 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Enteropathic Arthritis" (unspecified if ongoing), notes: Enteropathic Arthritis/Arthritis Associated With Inflammatory Bowel Disease; "Bowel disease" (unspecified if ongoing), notes: Enteropathic Arthritis/Arthritis Associated With Inflammatory Bowel Disease; "Small fiber peripheral neuropathy" (unspecified if ongoing); "vulvodynia" (unspecified if ongoing); "frequent PVCs" (unspecified if ongoing); "Allergies to pollen" (unspecified if ongoing); "allergies to mold" (unspecified if ongoing); "allergies to fungi" (unspecified if ongoing), notes: allergies to fungi; "Allergies to dander" (unspecified if ongoing); "allergies to dust" (unspecified if ongoing); "known allergies: food sensitivities, but not true allergic reactions" (unspecified if ongoing), notes: known allergies: food sensitivities, but not true, allergic reactions. The patient took concomitant medications. The following information was reported: JOINT SWELLING (non-serious) with onset 05Mar2021 08:00, outcome "not recovered", described as "Joint swelling"; FATIGUE (non-serious) with onset 05Mar2021, outcome "recovered" (07Mar2021), described as "Also had fatigue"; NECK PAIN (non-serious) with onset 05Mar2021 08:00, outcome "not recovered", described as "increase in neck pain.". Therapeutic measures were not taken as a result of joint swelling, fatigue, neck pain.  Additional information: The patient experienced joint swelling in right thumb PIP joint that was not previously swollen and in joints with some existing swelling became more swollen right ankle, left hip, right shoulder, right wrist and increase in neck pain. Joint swelling went down slightly then back up again after second dose. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. The AE did not result in emergency room or physician office visit.  No follow-up attempts are possible. No further information is expected.
12/24 @3pm - tingling and heat sensations throughout body, tingling in mouth. Sore arm.  12/25 @5am - total body aches, joints, bone pain , mild headache, increased heat and tingling sensation to face, bright red cheeks. Body temp normal to low-grade 99F. Fatigue. Self-treated with Tylenol x3 doses.  12/26 - body pain resolved, heat and tingling sensation continued until late morning.  Arm was red/hard/itchy 12/24 through 12/26.
Patient presented to opthamologist with one dilated pupil. Vision test returned normal (20/20).
No additional adverse effects reported; One female patient was inadvertently administered VARIVAX and M-M-R II before discovery of data logger malfunction; This spontaneous report was received from a medical assistant concerning a 12 month old female patient. There was no information about patient's concurrent conditions, medical history or concomitant medications.  On 17-FEB-2020, the patient was inadvertently vaccinated with a dose of improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) lot # S024364 with expiration date of 06-AUG-2021 and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live rHA(M-M-R II) lot #S018254 with expiration date of 19-MAY-2021 (route of administration and anatomical location were not reported) for prophylaxis, which were stored from 14-FEB-2020 after closing, to 17-FEB-2020, for 42 hours and 50 minutes; during the day the data logger malfunctioned. The malfunction was discovered after vaccinating the patient. The vaccines were reconstituted with properly stored sterile diluent(MERCK STERILE DILUENT) lot # S025291 with expiration date of 23-APR-2022. No previous temperature excursion was reported. No additional adverse effects were reported.  Digital data logger was involved.
My left arm puffed up on Saturday, late afternoon, evening. It was painful to touch around the vaccination spot and hurt to put pressure on. Sunday I ran a low fever; it reached 99.1 near the end of the Ibuprofen time limit (~ every 4 hours). I stayed wet with sweat and my back itched throughout the day. Food tasted bad--my stomach was sour. I was lethargic and slept most of Sunday and straight through Sunday night/Monday morning. My nose and cheeks pealed this (Monday) morning and I look as if I have a mild suntan. I haven't been in the sun or wind for more than a few minutes, for over a week and I haven't been outside at all since I received my vaccine.   The soreness in my arm is now only at the vaccination spot and it is tender only if I press it; touching it no longer causes wincing.  I feel flushed but no llonger have a fever. I'm no longer taking Ibuprofen. Food is tasting better today but it's not back to normal--my stomach is still a little sour.
17 Year old received 1st Shot; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 Year old received 1st Shot) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 Year old received 1st Shot). On 15-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 Year old received 1st Shot) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Diarrhea, headache, aching all over, pt states "felt like I was going to fall over, walked like I was drunk" - Lasted 3-4 days. "Much better now".
Approx 10 minutes post administering MMR + PPD, vaccine pt developed deep continuous cough and facial erythema, hives and mild inflammation.
He is currently a resident at the medical care facility.  Patient developed a cough and some mild shortness of breath over the last couple of days and tested positive for Covid this morning. His oxygen saturation is 95% on 3 L nasal cannula.  Patient states he feels fine but does admit to some mild congestion and cough.  He denies any shortness of breath beyond his normal state however does have some conversational dyspnea noted at rest.
Swelling in arm; sleeping more than 4 hours; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration in the left arm on 23Jun2021 at 12:15 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Jun2021 at 13:00, the patient experienced swelling in arm and was sleeping more than four hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events swelling in arm and sleeping more than 4 hours was resolving at the time of this report.
Upset stomach on got worse Thursday, headache got very intense-worst pain. I have ever experiences, foggy brain, nausea, Will be doing another COVID-19 test tomorrow.
Losing a lot of hair.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Mar2021 10:00 (Lot number: EN6208) at the age of 61 years as dose 1, single, administered in arm left, administration date 08Apr2021 10:00 (Lot number: EW0153) as dose 2, single and administered in arm left, administration date 31Aug2021 09:15 (Lot number: FC3183) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Diabetes" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: ALOPECIA (non-serious) with onset 15Mar2021, outcome "not recovered", described as "Losing a lot of hair.". Therapeutic measures were not taken as a result of alopecia.  Additional information: Patient prior to vaccination, was the patient diagnosed with COVID-19: No. Patient since the vaccination, has the patient been tested for COVID-19:No. Patient known allergies: no. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store.  No follow-up attempts are possible. No further information is expected.
This case was reported by a nurse and described the occurrence of abnormal menstrual cycle in a 23 year old female subject who was vaccinated with hepatitis A inactivated and Twinrix plus a separate injection of Tetanus diphtheria toxoid. Medical history included smoker. Concurrent medications included Ortho Novum. On 10 February 2006, the subject received a dose of Twinrix (lot AHABB026AC) plus a separate injection of Tetanus and diphtheria toxoids (lot U13408A). On 13 February 2006, 3 days after receipt of the vaccinations, the subject "received her menstrual cycle." The event resolved on 03 March 2006. The nurse considered the event to possibly be related to vaccination with Twinrix and Tetanus and diphtheria toxoids.
I got hot and my throat started to close up before I got dizzy and nauseous. Then my heartbeat spiked and I got really loopy and uncoordinated while having trouble breathing. That night I got the chills and a fever of 102.
DIPLOPIA, CONTINUING TO TODAY HYPERTENSION, IMPROVING ON ADDITION OF AMLODIPINE